We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Non-arteritic anterior ischemic optic neuropathy (NAION), a condition that can cause sudden deterioration in vision, usually in one eye at a time, has been very rarely reported in association with semaglutide in the treatment of type 2 diabetes, weight management...
Urgent and clinically significant safety updates arising from pharmacovigilance data, including reported adverse events, for veterinary medicines authorised in the UK.
List of words and phrases that will cause a veterinary product to be medicinal by presentation either through use or contextual use.
These reports explain our assessment of the scientific evidence used to lead to regulatory decisions on the safety of medicines or medicines classes.
Prescribing or supplying veterinary medicines including requirements for registration and inspection of premises.
Explanation for animal owners and veterinary health professionals on how the VMD calculates adverse event incidence rates for veterinary medicines
MHRA updates product information regarding the very rare risk of non-arteritic anterior ischemic optic neuropathy (NAION) in patients taking semaglutide.
The SIREN study has been investigating SARS-CoV-2 infections and acute respiratory illness in healthcare workers since 2020, and providing vital research into the immune response to infection and vaccination.
This publication focuses on statistical data of individuals referred to and supported through the Prevent programme from April 2015 to March 2016; it also includes statistical data of individuals referred to and supported through the Channel programme from April 2012...
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).